NCT06531161 EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT06530524 Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery Status NOT_YET_RECRUITING Phase PHASE2
NCT06530290 Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients Status RECRUITING Phase PHASE2
NCT06529419 A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations Status COMPLETED Phase PHASE2
NCT06528314 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH Status RECRUITING Phase PHASE3
NCT06528262 Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation Status RECRUITING Phase PHASE4
NCT06527404 A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06526377 Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy Status NOT_YET_RECRUITING Phase PHASE2
NCT06525935 A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity Status COMPLETED Phase PHASE2
NCT06525597 Study of Stapokibart Injection in Patients With Allergic Rhinitis Status RECRUITING Phase PHASE2
NCT06524739 Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS Status TERMINATED Phase PHASE3
NCT06523725 Trial Investigating the Safety and Efficacy of BRC-003 in Refractory Post-Traumatic Epilepsy Status WITHDRAWN Phase PHASE2
NCT06523400 The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Status RECRUITING Phase PHASE3
NCT06522997 A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease Status COMPLETED Phase PHASE2
NCT06521762 Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis Status WITHDRAWN Phase PHASE2
NCT06521476 Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder Status RECRUITING Phase PHASE2